However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may ...

Tumor markers can be used to detect relapse with a high degree of sensitivity in patients with central nervous system nongerminomatous germ cell tumors (CNS-NGGCTs), according to a pooled analysis ...

Ovarian cancer tumor markers are proteins that cancer cells produce. Healthcare professionals can test tumor marker levels in a person’s bloodstream and use them alongside imaging and biopsy ...

A new study suggests that rather than screening for disease, blood tumor markers could be useful in monitoring therapeutic outcomes in those with already established disease. For many years ...

The oldest known archaeological evidence of human cancer dates back 1.7 million years. Tumor markers are molecules produced by the tumor or by the body in response to the tumor and may reveal the ...

Doctors often monitor tumor markers in the blood to help diagnose and treat liver cancer. Alpha-fetoprotein (AFP) is the most common tumor marker that doctors monitor. Tumor markers, also called ...

After combined chemotherapy and radiation treatment, the tumor shrank significantly and tumor markers decreased (right image). Surgery was then recommended by the patient’s medical team.

Volume 11, Issue 28 of Oncotarget features "Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry" by Schmidt et, al. which reported that ...

New insights into a population of tumor-infiltrating T cells may ultimately ... higher quantities of T cells that expressed the CD200 marker, which became more common after anti-PD-L1 therapy ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

These so-called 'tumor markers' are traditionally associated with a single dominant cancer type, for example Prostate Specific Antigen (PSA) linked to prostate cancer, Carcinoembryonic antigen ...